Executive Order 14200
Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
This executive order amends a prior February 1, 2025 order on China tariffs by preserving duty-free de minimis treatment for covered articles temporarily, but establishing an automatic trigger to end that exemption once the Secretary of Commerce notifies the President that adequate systems exist to process and collect tariff revenue on those goods. It effectively delays but does not eliminate the removal of the de minimis exemption for Chinese imports targeted under the synthetic opioid supply chain tariffs.